Q2 2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Runben Biotechnology(603193) the Revenue is 786.78 M (+20.1%);the EBIT is 193.77 M (+20.42%);the EPS is 0.432 (+24.7%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.79B20.10%
----
----
EBIT
0.19B20.42%
----
----
EPS
0.432224.70%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf